Schott tracks pharmaceutical tubing

Published: 22-Jan-2014

Glassmaker issues one millionth certificate for its Fiolax glass tubes

Schott is supporting the pharmaceutical industry in its efforts to track the tubing used to produce pharmaceutical packaging made of glass. The company has recently issued its one millionth certificate for its Fiolax glass tubing.

These certificates help to identify the products shipped as tubing that are subsequently processed into pharmaceutical packaging, such as vials or syringes. They contain detailed information on the dimensional quality and the quality of the glass. This enables pharmaceutical companies to track their packaging all the way back to the raw material if necessary.

Traceability is currently one of the most pressing issues for the pharmaceutical industry. It is closely related to more stringent requirements for quality and safety in manufacturing, shipping and administering medicines. Packaging is thus an integral part of all safety considerations.

Schott says in 1999 it became the first company in the industry to allow for all of the pharmaceutical tubing it manufactures to be identified. The certificates are applied to the pallet in a clearly visible position and enable customers to inspect incoming shipments more easily because they contain detailed information. One part of the certificate can be detached and stored for documentation purposes and used to perform subsequent track and trace inside the e-commerce portal.

Schott’s certificates can be distinguished from those used by its competitors mainly by their depth of detail and clarity. Besides a description of the product that includes an exact definition of all of the characteristics of importance to the customer, they also contain highly detailed specifications on tolerances.

'In other words, we offer our customers the highest possible transparency and reliable quality,' commented Jürgen Achatz, Schott's Global Sales Director for Pharmaceutical Tubing.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like